EarningsNAVANAPHAR

NAVANAPHAR Earnings Update

Published
Last verified by BullBD

Announcement summary

What happened
NAVANAPHAR published a corporate disclosure on 30 January 2025. Read the full announcement for details.
Company
Navana Pharmaceuticals PLC
Announcement published

Original announcement

(Q2 Un-audited): EPS was Tk. 1.00 for October-December 2024 as against Tk. 0.98 for October-December 2023; EPS was Tk. 2.25 for July-December 2024 as against Tk. 2.09 for July-December 2023. NOCFPS was Tk. 3.16 for July-December 2024 as against Tk. 0.87 for July-December 2023. NAV per share was Tk. 44.10 as on December 31, 2024 and Tk. 42.46 as on June 30, 2024. NOCFPS has been increased due to cash received from customers was higher than cash payment to the vendors in the reporting period.

Bangla translation

A Bangla translation is under review because critical figures or dates did not match the English disclosure.

Source & verification

Source
Published company disclosure
Published through
Dhaka Stock Exchange
Announcement ID
679af79c658c52fc96a2af21
Original publication
Last verified by BullBD
Translation
BullBD
Report incorrect information

Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.